Re: Epidemiological study of anti-HPV-16/18 seropositivity and subsequent risk of HPV-16 and -18 infections

J Natl Cancer Inst. 2012 Jan 18;104(2):163; author reply 163-4. doi: 10.1093/jnci/djr517. Epub 2012 Jan 9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Viral / blood*
  • Female
  • Human papillomavirus 16 / immunology*
  • Human papillomavirus 18 / immunology*
  • Humans
  • Papillomavirus Infections / epidemiology*
  • Papillomavirus Infections / immunology*
  • Papillomavirus Vaccines / administration & dosage*

Substances

  • Antibodies, Viral
  • Papillomavirus Vaccines